Stocks to sell

The outlook of Carnival Corporation (NYSE:CCL) stock has improved in recent weeks, but given the cruise operator’s extremely high debt load and the great amount of uncertainty it continues to face, I still urge investors to sell their shares. Source: Ruth Peterkin / Shutterstock.com In addition to its highly elevated debt load, Carnival must deal

The party’s over once again for Clover Health (NASDAQ:CLOV) stock. A few months back, the insurtech company, and former SPAC (special purpose acquisition company), was a popular health care-related “story stock.” Source: Shutterstock News of a Department of Justice (DOJ) investigation fueled a big change in investor’s opinions about it. But starting in the spring,

Lordstown Motors (NASDAQ:RIDE) stock is becoming a cautionary tale for many investors in electric vehicle (EV) stocks. Source: Postmodern Studio / Shutterstock.com RIDE stock is down almost 50% in 2021. And that was the case before the company announced that its “backlog” of pre-orders do not represent binding commitment.   That announcement came on the heels of top

Clover Health (NASDAQ:CLOV) stock is up 57% in the last month. The price action highlights the uncertainty of investing in celebrity SPAC (special purpose acquisition company) plays. Source: Shutterstock Bit of background here. Venture capitalist and resident SPAC king Chamath Palihapitiya helped Clover, which sells Medicare-backed insurance plans, to go public through a $3.7 billion deal

Bionano Genomics (NASDAQ:BNGO) stock might appear interesting at first blush. After all, the company has developed an optical DNA mapping instrument called Saphyr. It is a high throughput system – which looks like a printer from the outside – that allows genome variations to be rapidly identified.  Source: Connect world / Shutterstock.com However, upon taking

I’ve been wrong twice about DraftKings (NASDAQ:DKNG) stock. I may be again. In June 2020, six months after DraftKings came public, I warned people to look out below. At the time the stock was at $42/share. It has since traded for as much as $72/share. In January 2021 I suggested there was still time to

Canoo (NASDAQ:GOEV) released its earnings on May 17 and made some concerning statements. Expect GOEV stock to drive lower. Source: Shutterstock For starters, the company is no longer going to use a contract manufacturer. It also expects to take until 2023 before electric vehicle (EV) deliveries and revenue begin to flow into the company. More troubling

Since the beginning of the year, shares of Cyprus-based shipping company Castor Maritime (NASDAQ:CTRM) stock are up by more than 80%. Source: Pavel Kapysh / Shutterstock.com As stated in its filings with the SEC back in April, its recent stock increases were “significantly inconsistent” with its performance. It continues to expand its fleet aggressively, putting

While it may seem like “meme-stock mania” is over, several of these names are still up triple digits this year. In fact, much-maligned meme stocks are not losing steam as the more than 10 million members of Reddit’s r/WallStreetBets (WSB) community continue to push shares upward. However — as is the case with most companies

Lordstown Motors (NASDAQ:RIDE) stock, the electric car start-up, took a hard fall but then rose again on a management re-shuffle. Source: Postmodern Studio / Shutterstock.com The company admitted misstatements in demand for its Endurance pick-up. Then it accepted the resignations of CEO Steve Burns and CFO Julio Rodriguez. Becky Roof, an accountant who has been

When I last wrote about Vaxart (NASDAQ:VXRT) last month I indicated that I felt that the biotech company was not worth more than about $1 per share. As of June 16, VXRT stock was at $7.67, or $1.00 higher than when I wrote about it on May 14 at $6.61. Source: Photo courtesy of Vaxart,

While Senseonics (NYSE:SENS) stock has a great deal of potential, the shares currently have a fairly high valuation. Source: Minerva Studio / Shutterstock.com Moreover, in the short-term and medium-term, SENS stock looks poised to fall significantly. Senseonics has developed Eversense, a 90-day continuous glucose monitoring (CGM) system. According to the company, the device provides continuous

With Zomedica’s  (NYSE:ZOM) new Truforma diagnostic tool possibly facing a great deal of entrenched competition, the outlook of ZOM stock is, at best, difficult to determine. Meanwhile, the shares have a very high valuation. Source: didesign021 / Shutterstock.com A diagnostic product meant to be used by veterinarians, Truforma measures the amount of T4 and TSH

Fisker (NYSE:FSR) detailed ongoing operating and capital spending plans in its latest Q1 earnings release on May 17. A capital raise looks likely for the electric vehicle (EV) car maker, and likely to wreak havoc on FSR stock, at least until investors have visibility on when, exactly, they can expect Fisker to start producing free

There’s been plenty of talk about GameStop (NYSE:GME) stock going to the moon in 2021. At the same time, there’s been plenty of people pounding the table that the stock is overvalued. Source: Northfoto / Shutterstock.com For sure, GME stock is overvalued compared to where it was just a year ago. The stock is up

A few months ago I tried to warn readers away from Castor Maritime (NASDAQ:CTRM). Source: Pavel Kapysh / Shutterstock.com I didn’t pull punches. I talked about how penny stocks are easy to manipulate. I even threw in some 19th century references. But some of you got in anyway. Maybe someone on Reddit told you this

For some strange reason, Reddit’s WallStreetBets embraced the short-squeeze of AMC Entertainment Holdings (NYSE:AMC). While its business is on the cusp of recovering, its earnings will not get anywhere near a level that justifies its valuation. Its market capitalization, which exceeded that of GameStop (NYSE:GME) at the end of last week, is most puzzling. For

QuantumScape (NYSE:QS) went from a hot special purpose acquisition company (SPAC) to damaged goods in record time. Back in December, QS stock traded for $130 per share. Just six months later, QuantumScape has lost a crushing 75% of its value. Source: Michael Vi / Shutterstock.com Why did electric vehicle (EV) battery maker QuantumScape power down

The economic numbers keep rolling in and they continue to look good. Jobless claims are falling. Hiring demand is rising. There’s money in the system. It’s all very attractive. But that’s what we’re seeing right now. The market isn’t really interested in right now. It’s looking at right now and making predictions on six months

Despite intense competition and the easing of the COVID pandemic restrictions, Zoom Video Communications (NASDAQ:ZM) is still zooming. ZM stock? Not so much. Zoom’s first fiscal quarter (April) results justified all the past faith that investors put into it. The company earned $227 million, 74 cents per share fully diluted, on revenue of $947 million.